GenEpic Product Information

Optimal
Health
Research
Content Copyright 2011-2023. All Rights Reserved

Optimal
Health
Research
A Therapeutic nutritional formula, specifically,
formulated to restore essential nutrients lost due to
stress, aging and disease.
It includes:

Optimal
Health
Research
CAUTION
This information is for educational
purposes.
Individuals suffering from any malady or
its effects should seek the care of a
medical professional.
The statements contained in this
presentation have not been reviewed
by the FDA.
Do not take if pregnant

Optimal
Health
Research
The Benefits of Vitamins
in conjunction with Chemo and Radiation
Purpose
Some in the oncology community contend that patients undergoing chemotherapy - radiation therapy should not use antioxidants and other
nutrients. Oncologists contended, antioxidants interfere with radiation and some chemotherapies, and that folic acid interferes with
methotrexate. This is despite the common use of amifostine and dexrazoxane, 2 prescription antioxidants, during chemotherapy and/or
radiation therapy.
Design
To assess all evidence concerning antioxidant and other nutrients used concomitantly with chemotherapy and/or radiation therapy. The
MEDLINE® and CANCERLIT® databases were searched from 1965 to November 2003 using the words vitamins, antioxidants, chemotherapy,
and radiation therapy. Bibliographies of articles were searched. All studies reporting concomitant nutrient use with chemotherapy and/or
radiation therapy (280 peer-reviewed articles including 62 in vitro and 218 in vivo) were indiscriminately included.
Results
Fifty human clinical randomized or observational trials have been conducted, involving 8,521 patients using beta-carotene; vitamins A, C, and
E; selenium; cysteine; B vitamins; vitamin D3; vitamin K3; and glutathione as single agents or in combination.
Conclusions
Since the 1970s, 468 peer-reviewed in vitro and in vivo studies, including 91 human studies involving 12,991 patients, 7,181 of whom were
given nutrients, have consistently shown that they do not interfere with therapeutic modalities for cancer. Furthermore, non-prescription
antioxidants and other nutrients enhance the killing of therapeutic modalities for cancer, decrease their side effects, and protect normal tissue.
In 26 human studies,5,238 patients who took non-prescription antioxidants and other nutrients
actually had increased survival.
Charles B. Simone II, MD, and Nicole L. Simone, MD, are consulting physicians, Victoria Simone, RN, is a research nurse, and Charles B.
Simone, MD, is a consulting physician and medical director, all at the Simone Protective Cancer Institute in Lawrenceville, NJ.
Altern Ther Health Med. 2007;13(2):40-46.
See full report at

Optimal
Health
Research
Conclusion, 468 peer-reviewed in vitro and in vivo
studies, including 91 human studies involving 12,991
patients, 7,181 of whom were given nutrients, have
consistently shown that they do not interfere with
therapeutic modalities for cancer. Furthermore, non-
prescription antioxidants and other nutrients enhance
the killing of therapeutic modalities for cancer,
decrease their side effects, and protect normal tissue.
In 26 human studies, 5,238 patients who took non-prescription
antioxidants and other nutrients actually had increased survival.

Optimal
Health
Research
Goals of Nutrition Therapy
Patients who are undergoing active therapy, recovering, or in remission and
striving to avoid cancer recurrence, the benefit of optimal caloric and nutrient
intake is well documented.
The goals of nutrition therapy are to accomplish the following:
• Prevent or reverse nutrient deficiencies
• Preserve lean body mass
• Help patients better tolerate treatments
• Minimize nutrition-related side effects and complications
• Maintain strength and energy
• Protect immune function, decreasing the risk of infection
• Aid in recovery and healing
• Maximize quality of life
Source: NIH National Cancer Institute / Cancer.Gov:

Optimal
Health
Research
ClinicalTrials.gov

Optimal
Health
Research
NCT01987999 Eradication of Prostate Cancer Using
GenEpic™ (F-989)

Optimal
Health
Research
1st IRB - Prostate Study Results
GenEpic™ taken for 12 months
• 60 Prostate Cancer Patients, each
confirmed with biopsy
• Each Patient took GenEpic™ daily
for 12 months
– No surgery, chemo or radiation
• Includes Patient Reports on
– PSA Scores
– Gleason Scores
– Negative Side Effects
• Average PSA Scores dropped from
10.07 to 1.48
• Average Gleason Scores dropped
from 6.45 to 0.33
Example:
A patient with an initial PSA of 54.6 and a
Gleason Score of 10 now has a zero score in
both categories.
• The 60 patients reported virtually no
major negative side-effects

Optimal
Health
Research
GenEpic™ use dramatically decreases PSA score in prostate cancer patients

Optimal
Health
Research
Supportive data
under the
Clinical Trial tab
GenEpic™ Clinical Trial PSA Scores

Optimal
Health
Research
GenEpic™ use dramatically decreases Gleason score in prostate cancer patients
Score

Optimal
Health
Research
GenEpic™ Clinical Trial Gleason Scores

Optimal
Health
Research
NCT02286778 Eradication of Malignant Carcinoma in
the Breast Tissue

Optimal
Health
Research
• 60 were enrolled, with an initial diagnoses of Stage I to Stage IV, Malignant
Carcinoma in the Breast Tissue.
• Each was confirmed by a Fine Needle Aspiration Biopsy (FNAB) or Breast Biopsy
(BB), and MRI.
• Participants were randomly assigned to one of three groups.
1. GenEpic™ Group - 1 packet of GenEpic™ twice daily, and dietary changes
2. Placebo Group - Took Placebo
3. Control Group - Took Nothing
No patient received surgery, chemo or radiation before or during the Clinical Trial.
IRB - Double Blind Placebo Controlled
Breast Cancer Clinical Trial

Optimal
Health
Research
Group 1 - GenEpic™ Group - 19 of the 20 patients experienced positive results.
Decreased tumor size months 3 to 9
No discernible tumor at the end of 12 months.
Group 2 - Placebo Group
1 patient experienced tumor shrinkage during the 12 month period,
5 showed signs of no change.
15 experienced tumor enlargement.
At 6 months the 15 unresponsive patients removed from of the clinical trial.
Group 3 - Control Group - No Treatment
No positive signs all participants removed from Study by the end of month 4.
The patients using GenEpic™ reported on the positive experience of drinking two glasses
daily, as opposed to suffering the side effects of chemotherapy, radiation or surgery.
Breast Clinical Trial (Continued)

Optimal
Health
Research
0
18
35
53
70
Start Mo 2 Mo4 Mo6 Mo8 Mo10 Mo12
CA15-3
Level
(Unit)
Treatment time
ReaLife+
0.
17.5
35.
52.5
70.
CA15-3
Level
(Unit)
Treatment time
Placebo
0.
5.
10.
15.
20.
25.
30.
35.
40.
45.
50.
55.
60.
65.
70.
Start Mo 2 Mo4
CA15-3
Level
(Unit)
Treatment time
Control
ReaLife+ dramatically reduces CA15-3 levels in breast cancer pat

Optimal
Health
Research
ReaLife+ dramatically reduces CEA levels in breast cancer patien
0
55
110
165
220
275
Start Mo 2 Mo4 Mo6
CEA
Level
(Unit)
Treatment time
Control
0
60
120
180
240
300
CEA
Level
(Unit)
Treatment time
Placebo
0
75
150
225
CEA
Level
(Unit)
Treatment time
ReaLife+

Optimal
Health
Research
Content Copyright 2011-2023. All Rights
Reserved
Breast Clinical Trial Results
Group Stage Clear Group Stage Out Group Stage Out
2 C 1 O 2 O
# 1 1 C # 2 1 O # 3 1 O
ReaLife 1 C Placebo 4 O Control 4 O
Plus 3 C 3 O 3 O
2 C 4 O 4 O
2 C 4 O 2 O
3 C 3 O 2 O
4 C 3 O 1 O
1 C 1 O 3 O
4 C 2 O 1 O
4 C 2 O 1 O
2 C 3 O 1 O
1 C 2 O 2 O
1 C 1 C 2 O
1 C 1 O 2 O
3 Out 2 O 1 O
2 C 2 O 3 O
2 C 1 O 1 O
3 C 3 O 4 O
2 C 1 O 4 O

Optimal
Health
Research
NCT05137067 A Novel Approach for Alleviating the
Side Effects of Chemotherapeutic Agents.

Optimal
Health
Research
SIDE EFFECTS
START
MILD
MOD-
SEVERE PTS
MO 2
MILD
MOD-
SEVERE PTS
MO 3
MILD
MOD-
SEVERE PTS
NONE ERATE NONE ERATE NONE ERATE
Fatigue 12 26 38 8 9 10 11 38 33 5 38
Weight Loss 4 19 15 38 15 23 38 36 2 38
Anxiety 11 18 9 38 7 11 14 6 38 29 9 38
Hair Loss 4 3 4 27 38 4 9 10 15 38 31 5 2 38
Moodiness 19 13 6 38 0 27 11 38 26 12 38
Fuzzy Thinking 25 10 3 38 25 10 3 38 19 19 38
Irritability 3 12 19 4 38 17 9 8 4 38 37 1 38
Insomnia 8 15 7 8 38 17 12 9 38 31 7 38
Headaches 10 1 12 15 38 10 17 6 5 38 30 8 38
Emotional Swings 13 19 6 38 19 13 5 1 38 35 3 38
Depression 10 15 13 38 13 11 9 5 38 26 10 2 38
Weight Gain 38 38 38 38 38 38
Short Term Memory Loss 11 17 7 3 38 16 15 5 2 38 29 9 38
Inability to Concentrate 8 19 6 5 38 12 23 2 1 38 13 23 2 38
Diarrhea 21 1 13 3 38 27 3 5 3 38 38 38
Shortness of Breath 38 38 38 38 38 38
Heart Palpitations 38 38 38 38 38 38
Sleep Disorders 1 35 2 38 20 5 11 2 38 32 6 38
Nausea 4 33 1 38 10 8 19 1 38 32 3 2 1 38
Dry Hair/Skin 38 38 38 38 38 38
Skin Rash 14 11 9 4 38 23 15 38 38 38
Stiff Joints 8 23 2 5 38 20 15 3 38 36 2 38
Swelling in Extremes 10 13 8 7 38 12 20 5 1 38 29 9 38
Bloating 19 11 7 1 38 19 11 7 1 38 35 3 38
Stomach Cramps 13 8 17 38 20 15 3 38 37 1 38
Increased Thirst 15 9 14 38 15 9 14 38 26 12 38
Increased Urination 13 8 10 7 38 32 6 38 37 1 38
•We continued to follow their complaints throughout the study with the use of GenEpic™, taking 1 packet twice daily.
These side effects
were compiled from
38 patients that were
actively receiving
Chemo or Radiation
Therapies and
GenEpic™ reduced
the debilitating side
effects of the
traditional therapies.
13 Breast
11 Prostate
4 Skin
3 Liver
2 Cervical
1 Gastric
1 Glioblastoma
1 Ovarian
2 Other
38 Total
Reduction of Side Effects with GenEpic™

Optimal
Health
Research
Virtually No Major Negative Side-Effects
Complaints of Prostate Clinical Trial Subjects
Before Taking ReaLife + While Taking ReaLife +
COMMON COMPLAINTS
INCLUDED:
Weight Loss or Gain
Hair Loss
Short Term Memory Loss
Heart Palpitations
Bloating
Fatigue…
(Many of the 60 patients reported multiple symptoms
before taking ReaLife+, but following month 3, no
complaints or negative side-effects were reported)

Optimal
Health
Research
HOW DOES IT WORK?

Optimal
Health
Research
EVERY CANCER CELL
HAS ONE THING
IN COMMON…
ATP Consumption
(Adenosine TriPhosphate)

Optimal
Health
Research
What is ATP?
• ATP (adenosine triphosphate) is the energy currency of the cell
• ATP transfers energy from chemical bonds to endergonic (energy absorbing)
reactions within the cell
• Structurally, ATP consists of the adenine nucleotide
– Ribose Sugar
– Adenine Base
– Phosphate Group
– Calcium Phosphate (po4)2
– Plus two other phosphate groups
• In non-technical terms, ATP is the
energy source for cellular division

Optimal
Health
Research
Content Copyright 2011-2019.All Rights
Reserved
ATP and Cancer Cells
• Cells operate similarly
– Regular cells can operate and reproduce on limited ATP.
– Cancer cells require a lot of ATP to reproduce rapidly –
they cannot survive a reduction of ATP, or they will die.
• ATP inhibition in cancer cells is similar to gasoline consumption
in automobiles.
– Cancer cells can be considered
gas guzzling SUV’s.
– Normal cells are like fuel
efficient hybrid cars.
– Using the same amount of gas the SUV will become immobile, while the
hybrid car keeps on running.

GenEpic Product Information

Recommended

Recommended

More Related Content

Similar to GenEpic Product Information

Similar to GenEpic Product Information (20)

Recently uploaded

Recently uploaded (20)

GenEpic Product Information